These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 7514324)

  • 1. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
    Bååth L; Widell A; Nordenfelt E
    J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
    Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
    J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between different hepatitis C virus screening and confirmatory assays.
    Berger A; Doerr HW; Preiser W; Weber B
    J Virol Methods; 1996 May; 59(1-2):141-6. PubMed ID: 8793841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
    François M; Dubois F; Brand D; Bacq Y; Guerois C; Mouchet C; Tichet J; Goudeau A; Barin F
    J Clin Microbiol; 1993 May; 31(5):1189-93. PubMed ID: 7684749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests.
    Prohaska W; Schroeter E; Kaars-Wiele P; Kleesiek K
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):397-404. PubMed ID: 1381965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial experiences with HCV detection and confirmation tests of the 3rd generation].
    Knödler B; Kühnl P
    Beitr Infusionsther; 1993; 31():10-5. PubMed ID: 7693234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
    Zaaijer HL; Vallari DS; Cunningham M; Lesniewski R; Reesink HW; van der Poel CL; Lelie PN
    J Med Virol; 1994 Dec; 44(4):395-7. PubMed ID: 7534821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction.
    De Beenhouwer H; Verhaert H; Claeys H; Vermylen C
    Vox Sang; 1992; 63(3):198-203. PubMed ID: 1333136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.